[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355660-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355660-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","dna-methylation-signatures-associated-with-smoking-status-across-lung-cancer-subtypes-using-the-cancer-genome-atlas-tcga-methylation-data","DNA Methylation Signatures Associated With Smoking Status Across Lung Cancer Subtypes Using The Cancer Genome Atlas (TCGA) Methylation Data","","Lung cancer is the leading cause of cancer-related mortality worldwide, with cigarette smoking as its strongest etiologic factor. Beyond genetic mutations, smoking can trigger epigenetic changes, especially DNA methylation, which may vary across lung cancer subtypes and shape tumor heterogeneity. This retrospective study identifies smoking-associated differentially methylated CpG sites using TCGA 450K methylation data and improves biological interpretation through genomic annotation, gene associations, and regulatory context.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/dna-methylation-signatures-associated-with-smoking-status-across-lung-cancer-subtypes-using-the-cancer-genome-atlas-tcga-methylation-data/355660/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/dna-methylation-signatures-associated-with-smoking-status-across-lung-cancer-subtypes-using-the-cancer-genome-atlas-tcga-methylation-data/355660.png","ImageObject",300,407,{"name":42,"@type":43},"Aditya","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the objective of the study?","Question",{"text":63,"@type":64},"The study aimed to identify smoking-associated differentially methylated CpG sites across lung cancer subtypes using TCGA 450K methylation data and to annotate their genomic context and functional relevance.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were differential methylation results determined?",{"text":68,"@type":64},"The study used retrospective analysis of Illumina HumanMethylation450 BeadChip data and multivariable linear models to compare smokers versus never smokers, adjusting for age, sex, tumor stage, and histology, with FDR correction.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key findings regarding CpG sites and subtypes?",{"text":72,"@type":64},"Seven CpG sites were significantly associated with smoking status overall, and subtype-specific analyses found eight LUAD-specific and five LUSC-specific CpG sites. LUAD showed both hypermethylation and hypomethylation, while LUSC showed predominantly smoking-related hypomethylation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355660,1790194010,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962085564549,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Review began 03/22/2026  \nReview ended 04/02/2026  \nPublished 04/06/2026  \n© Copyright 2026  \nOjinna et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0. , which permits unrestricted use , distribution , and reproduction in any medium , provided the original author and source are credited.  \nDOI: 10.7759/cureus.106555  \nOpen Access Original Article  \nDNA Methylation Signatures Associated With Smoking Status Across Lung Cancer Subtypes Using The Cancer Genome Atlas (TCGA) Methylation Data  \nBlessing T. Ojinna 1, 2, Abimbola E. Arisoyin 3, Akinyele Oladimeji 4, Chigozirim Okpechi 5, Azeberoje Osueni 6  \n1. Internal Medicine, Guthrie Lourdes Hospital, Binghamton, USA 2. Global Health, Emory University Rollins School of Public Health, Atlanta, USA 3. Psychiatry, Harlem Hospital Center, New York, USA 4. Family Medicine, Obafemi Awolowo University, Ile-Ife, NGA 5. Medicine, St George’s University, St. George 's, GRD 6. Gastroenterology and Hepatology, Lagos University Teaching Hospital, Lagos, NGA  \nCorresponding author: Abimbola E. Arisoyin, [abimbolaarisoyin@gmail.com](abimbolaarisoyin@gmail.com)  \nAbstract  \nBackground: Lung cancer remains the leading cause of cancer-related mortality worldwide, with cigarette smoking as its strongest etiologic factor. Beyond genetic mutations, smoking induces epigenetic alterations, particularly DNA methylation, which may differ across lung cancer subtypes and contribute to tumor heterogeneity.  \nObjective: The objective of this study was to identify smoking-associated differentially methylated CpG sites (FDR \u003C 0 .05) across lung cancer subtypes using The Cancer Genome Atlas (TCGA) 450K methylation data, and to enhance biological interpretation by annotating their genomic context and functional relevance, including associated genes and regulatory features.  \nMethodology: This retrospective observational study analyzed Illumina HumanMethylation450 BeadChip data from TCGA lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) cohorts. Multivariable linear models within the limma framework assessed differential methylation between smokers and never smokers, adjusting for age, sex, tumor stage, and histology. False discovery rate (FDR) correction was applied.  \nResults: A total of 771 patients (92 never smokers, 679 smokers) were analyzed. Seven CpG sites were significantly associated with smoking status (FDR \u003C 0 .05), with absolute methylation differences (Δβ) ranging from 0.100 to 0.123. Subtype-specific analyses identified eight LUAD-specific and five LUSC-specific smoking-associated CpG sites. LUAD exhibited both hypermethylation and hypomethylation patterns, whereas LUSC showed predominantly smoking-related hypomethylation.  \nConclusion: Smoking is associated with distinct and subtype-specific DNA methylation signatures in lung cancer, underscoring its role in epigenetic tumor modulation and supporting the potential utility of methylation markers in lung cancer stratification and risk assessment.  \nCategories: Genetics, Epidemiology/Public Health, Oncology  \nKeywords: dna methylation, epigenetics, lung cancer, non-small cell lung cancer, smoking, tcga  \nIntroduction  \nWorldwide, lung cancer has remained the leading cause of cancer mortality and has been found to constitute a significant proportion of cancer deaths in the world [1] . Regardless of the progress in diagnosis and treatment, prognosis is poor in most patients with the disease, mainly because the diagnosis is late, and the disease is biologically heterogeneous [2] . The most important contribution to the etiology of lung cancer is cigarette smoking, which causes most, but not all, cases, and molecular and genetic factors play an essential role in lung carcinogenesis [3,4] . The role of smoking in promoting the molecular changes in various subtypes of lung cancer is thus important in enhancing risk stratification, early diagnosis, and treatment decisions [","cbCaiifHdppcYVoj","https://ap.wps.com/l/cbCaiifHdppcYVoj","pdf",1079080,11,"English","# Abstract\n## Background\n## Objective\n## Methodology\n## Results\n## Conclusion\n# Introduction\n## Lung cancer overview and heterogeneity\n## Smoking as an etiologic factor\n## NSCLC subtypes: LUAD and LUSC","[{\"question\":\"What was the objective of the study?\",\"answer\":\"The study aimed to identify smoking-associated differentially methylated CpG sites across lung cancer subtypes using TCGA 450K methylation data and to annotate their genomic context and functional relevance.\"},{\"question\":\"How were differential methylation results determined?\",\"answer\":\"The study used retrospective analysis of Illumina HumanMethylation450 BeadChip data and multivariable linear models to compare smokers versus never smokers, adjusting for age, sex, tumor stage, and histology, with FDR correction.\"},{\"question\":\"What were the key findings regarding CpG sites and subtypes?\",\"answer\":\"Seven CpG sites were significantly associated with smoking status overall, and subtype-specific analyses found eight LUAD-specific and five LUSC-specific CpG sites. LUAD showed both hypermethylation and hypomethylation, while LUSC showed predominantly smoking-related hypomethylation.\"}]","DNA Methylation Signatures Associated With Smoking Status Across Lung Cancer Subtypes Using The Cancer Genome Atlas (TCGA) Methylation Data | PDF",1790120392,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1576b6f0343557aefad65427e33fc3a9.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b24a958f264ab153061712c963c99084.webp",982,1389,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cc3c421fa0eac7102d6c5a132565ab10.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4b293b2ce81515dfc65996bf612459f.webp",980,1386]